Dopamine Agonists: From the 1970s to Today.
Neuroendocrinology
; 109(1): 34-41, 2019.
Article
en En
| MEDLINE
| ID: mdl-30852578
ABSTRACT
The discovery of dopamine inhibitory effects on prolactin secretion has led to an era of successful dopaminergic therapy for prolactinomas. Herein we provide an overview of the evolution of dopamine agonists and their use in patients with PRL-secreting pituitary tumors, starting from the 1970s up to today, highlighting that normalization of PRL levels, restoration of eugonadism, and reduction of tumor mass can be achieved in the majority of patients by treatment with dopamine agonists.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Neoplasias Hipofisarias
/
Prolactinoma
/
Agonistas de Dopamina
Límite:
Humans
Idioma:
En
Revista:
Neuroendocrinology
Año:
2019
Tipo del documento:
Article
País de afiliación:
Italia